{
    "componentChunkName": "component---src-templates-operator-page-tsx",
    "path": "/en/operators/oriola",
    "result": {"data":{"contentfulOperator":{"contacts":[{"displayName":"Tuire Prami","email":"tuire.prami@oriola.com","id":"d01a87b6-4005-505a-a790-6c2d0033fa65","phone":"+358 50 546 8459","responsibility":"Real World Evidence Team Lead","title":"Principal Pharmacoepidemiologist","image":null,"kind":null}],"coverImage":{"file":{"contentType":"image/jpeg","url":"//images.ctfassets.net/7e3gy8pq6aym/6G7p0KXba5HF7E0I40ApmF/44b6e1465b9a6bab839a6a1d0a4e5fb7/Oriola-0182.jpg"},"gatsbyImageData":{"images":{"sources":[{"srcSet":"//images.ctfassets.net/7e3gy8pq6aym/6G7p0KXba5HF7E0I40ApmF/44b6e1465b9a6bab839a6a1d0a4e5fb7/Oriola-0182.jpg?w=640&h=427&q=50&fm=webp 640w,\n//images.ctfassets.net/7e3gy8pq6aym/6G7p0KXba5HF7E0I40ApmF/44b6e1465b9a6bab839a6a1d0a4e5fb7/Oriola-0182.jpg?w=1280&h=854&q=50&fm=webp 1280w,\n//images.ctfassets.net/7e3gy8pq6aym/6G7p0KXba5HF7E0I40ApmF/44b6e1465b9a6bab839a6a1d0a4e5fb7/Oriola-0182.jpg?w=2560&h=1707&q=50&fm=webp 2560w,\n//images.ctfassets.net/7e3gy8pq6aym/6G7p0KXba5HF7E0I40ApmF/44b6e1465b9a6bab839a6a1d0a4e5fb7/Oriola-0182.jpg?w=4000&h=2667&q=50&fm=webp 4000w","sizes":"(min-width: 2560px) 2560px, 100vw","type":"image/webp"}],"fallback":{"src":"//images.ctfassets.net/7e3gy8pq6aym/6G7p0KXba5HF7E0I40ApmF/44b6e1465b9a6bab839a6a1d0a4e5fb7/Oriola-0182.jpg?w=2560&h=1707&fl=progressive&q=50&fm=jpg","srcSet":"//images.ctfassets.net/7e3gy8pq6aym/6G7p0KXba5HF7E0I40ApmF/44b6e1465b9a6bab839a6a1d0a4e5fb7/Oriola-0182.jpg?w=640&h=427&fl=progressive&q=50&fm=jpg 640w,\n//images.ctfassets.net/7e3gy8pq6aym/6G7p0KXba5HF7E0I40ApmF/44b6e1465b9a6bab839a6a1d0a4e5fb7/Oriola-0182.jpg?w=1280&h=854&fl=progressive&q=50&fm=jpg 1280w,\n//images.ctfassets.net/7e3gy8pq6aym/6G7p0KXba5HF7E0I40ApmF/44b6e1465b9a6bab839a6a1d0a4e5fb7/Oriola-0182.jpg?w=2560&h=1707&fl=progressive&q=50&fm=jpg 2560w,\n//images.ctfassets.net/7e3gy8pq6aym/6G7p0KXba5HF7E0I40ApmF/44b6e1465b9a6bab839a6a1d0a4e5fb7/Oriola-0182.jpg?w=4000&h=2667&fl=progressive&q=50&fm=jpg 4000w","sizes":"(min-width: 2560px) 2560px, 100vw"}},"layout":"constrained","backgroundColor":"#e8e8e8","width":2560,"height":1707}},"description":{"raw":"{\"nodeType\":\"document\",\"data\":{},\"content\":[{\"nodeType\":\"paragraph\",\"data\":{},\"content\":[{\"nodeType\":\"text\",\"value\":\"Oriola is a health and wellbeing company operating in Finland and Sweden. As a strategic partner for pharmaceutical companies, Oriola's expert services support companies throughout the entire lifecycle of medicines, including Real World Evidence and Patient Reported Outcome (PRO) research as well as Market Access services.\",\"marks\":[],\"data\":{}}]},{\"nodeType\":\"paragraph\",\"data\":{},\"content\":[{\"nodeType\":\"text\",\"value\":\"Powered by our pharmaceutical warehousing and distribution services, we ensure reliable and safe delivery of pharmaceuticals to pharmacies, hospital pharmacies, veterinarians, and other healthcare operators. We are proud of our expertise and our important role in the society in building a healthier tomorrow.\",\"marks\":[],\"data\":{}}]},{\"nodeType\":\"paragraph\",\"data\":{},\"content\":[{\"nodeType\":\"text\",\"value\":\"Oriola approaches health data collection by combining patient perspective from patient reported outcome (PRO) studies with register data and RWE. This way, a more comprehensive view of disease burden can be attained to improve treatment outcomes and the patients’ quality of life. Oriola collects real-world data from national registries and hospital data lakes, including medical record data of public and private healthcare providers. \",\"marks\":[],\"data\":{}}]},{\"nodeType\":\"paragraph\",\"data\":{},\"content\":[{\"nodeType\":\"text\",\"value\":\"The main participant recruitment site in PRO studies is Oriola’s unique Research Pharmacy Network that includes more than 180 research pharmacies in Finland.\",\"marks\":[],\"data\":{}}]},{\"nodeType\":\"paragraph\",\"data\":{},\"content\":[{\"nodeType\":\"text\",\"value\":\"\",\"marks\":[],\"data\":{}}]},{\"nodeType\":\"paragraph\",\"data\":{},\"content\":[{\"nodeType\":\"text\",\"value\":\"Use Case - \",\"marks\":[],\"data\":{}},{\"nodeType\":\"hyperlink\",\"data\":{\"uri\":\"https://site.fingenious.fi/en/articles/ecosystem-article-rwe-studies-in-oriola-the-clinical-and-economic-burden-of\"},\"content\":[{\"nodeType\":\"text\",\"value\":\"New from Oriola RWE Team: The clinical and economic burden of pneumonia and pneumococcal disease in Finland\",\"marks\":[],\"data\":{}}]},{\"nodeType\":\"text\",\"value\":\"\",\"marks\":[],\"data\":{}}]}]}","references":[]},"displayName":"Oriola","fields":{"route":"/operators/oriola"},"logo":{"file":{"url":"//images.ctfassets.net/7e3gy8pq6aym/7EpayOTCiSAsZlO4rogcc4/1d68508845ef11469464aff38ee5cb46/Oriola_Logo_Raster_Orange_RGB.jpg"},"gatsbyImageData":{"images":{"sources":[{"srcSet":"//images.ctfassets.net/7e3gy8pq6aym/7EpayOTCiSAsZlO4rogcc4/1d68508845ef11469464aff38ee5cb46/Oriola_Logo_Raster_Orange_RGB.jpg?w=160&h=67&q=50&fm=webp 160w,\n//images.ctfassets.net/7e3gy8pq6aym/7EpayOTCiSAsZlO4rogcc4/1d68508845ef11469464aff38ee5cb46/Oriola_Logo_Raster_Orange_RGB.jpg?w=320&h=135&q=50&fm=webp 320w,\n//images.ctfassets.net/7e3gy8pq6aym/7EpayOTCiSAsZlO4rogcc4/1d68508845ef11469464aff38ee5cb46/Oriola_Logo_Raster_Orange_RGB.jpg?w=640&h=269&q=50&fm=webp 640w,\n//images.ctfassets.net/7e3gy8pq6aym/7EpayOTCiSAsZlO4rogcc4/1d68508845ef11469464aff38ee5cb46/Oriola_Logo_Raster_Orange_RGB.jpg?w=1280&h=538&q=50&fm=webp 1280w","sizes":"(min-width: 640px) 640px, 100vw","type":"image/webp"}],"fallback":{"src":"//images.ctfassets.net/7e3gy8pq6aym/7EpayOTCiSAsZlO4rogcc4/1d68508845ef11469464aff38ee5cb46/Oriola_Logo_Raster_Orange_RGB.jpg?w=640&h=269&fl=progressive&q=50&fm=jpg","srcSet":"//images.ctfassets.net/7e3gy8pq6aym/7EpayOTCiSAsZlO4rogcc4/1d68508845ef11469464aff38ee5cb46/Oriola_Logo_Raster_Orange_RGB.jpg?w=160&h=67&fl=progressive&q=50&fm=jpg 160w,\n//images.ctfassets.net/7e3gy8pq6aym/7EpayOTCiSAsZlO4rogcc4/1d68508845ef11469464aff38ee5cb46/Oriola_Logo_Raster_Orange_RGB.jpg?w=320&h=135&fl=progressive&q=50&fm=jpg 320w,\n//images.ctfassets.net/7e3gy8pq6aym/7EpayOTCiSAsZlO4rogcc4/1d68508845ef11469464aff38ee5cb46/Oriola_Logo_Raster_Orange_RGB.jpg?w=640&h=269&fl=progressive&q=50&fm=jpg 640w,\n//images.ctfassets.net/7e3gy8pq6aym/7EpayOTCiSAsZlO4rogcc4/1d68508845ef11469464aff38ee5cb46/Oriola_Logo_Raster_Orange_RGB.jpg?w=1280&h=538&fl=progressive&q=50&fm=jpg 1280w","sizes":"(min-width: 640px) 640px, 100vw"}},"layout":"constrained","backgroundColor":"#f8f8f8","width":640,"height":269}},"metaDescription":{"metaDescription":"Oriola is a health and wellbeing company operating in Finland and Sweden. As a strategic partner for pharmaceutical companies, Oriola's expert services support companies throughout the entire lifecycle of medicines, including Real World Evidence and Patient Reported Outcome (PRO) research as well as Market Access services."},"partnerLinks":null,"referenceLinks":null,"services":[{"id":"0cec0734-69fa-5953-8a42-4fb30b56bebd","description":{"raw":"{\"data\":{},\"content\":[{\"data\":{},\"content\":[{\"data\":{},\"marks\":[],\"value\":\"Oriola gathers valuable information from patients about their medical treatments through its Research Pharmacy Network. Oriola RWE (real-world evidence) conducts surveys that provide up-to-date information on e.g., the patients’ quality of life and health behavior. In addition to the Research Pharmacy Network (around 180 pharmacies in Finland), Oriola collects data from patient organizations, and private healthcare providers. Together with the Research Pharmacies, Oriola carries out several significant patient-reported outcomes (PRO)studies of different therapeutic areas every year. \",\"nodeType\":\"text\"}],\"nodeType\":\"paragraph\"},{\"data\":{},\"content\":[{\"data\":{},\"marks\":[],\"value\":\"Combining real-world data (RWD) with PRO, Oriola gets a comprehensive picture of the disease burden. RWE combines the patients’ perspective to nationwide health register data. Oriola’s RWE studies benefit the entire healthcare value chain. Research pharmacy customers, the patients, are motivated to participate in the development of pharmacotherapy in order to find remedies for their conditions and to contribute to a common goal.\",\"nodeType\":\"text\"}],\"nodeType\":\"paragraph\"}],\"nodeType\":\"document\"}","references":[]},"displayName":"Patient-Reported Outcomes","referenceLinks":[{"id":"1d38f3af-842f-59bb-9441-4064cc233d92","description":null,"text":"Case examples of Oriola's patient report outcomes (PRO) projects","url":"https://www.oriola.com/news-and-releases/news/2020/case-examples-of-our-patient-report-outcomes-pro-projects"}],"website":"https://www.oriola.com/services/pharmaceutical-companies/real-world-evidence"},{"id":"1b594f1a-aa4d-58cf-adb6-18f87a9c0866","description":{"raw":"{\"data\":{},\"content\":[{\"data\":{},\"content\":[{\"data\":{},\"marks\":[],\"value\":\"Oriola can provide you with strategic support throughout the entire lifespan of medical products. The company offers valuable data-driven information and services for successful progress from clinical phases to the post-marketing phase IV. Oriola collects real-world data (RWD) from national registers, hospital data-lakes (including various electronic medical records), and private healthcare providers, and combines this with patient-reported outcomes (PRO) measures.\",\"nodeType\":\"text\"}],\"nodeType\":\"paragraph\"},{\"data\":{},\"content\":[{\"data\":{},\"marks\":[],\"value\":\"The real-world data (RWE) experts at Oriola are highly experienced in post-doctoral research, pharmacoepidemiology, registry studies (including EMA and FDA PASS), and analytics, including machine learning. Oriola's skilled teams have extensive experience with working with nation-wide data in the Nordic countries. Oriola's experts come from backgrounds in CROs, big pharma, universities, university hospitals, pharmacies, and national regulatory agencies.\",\"nodeType\":\"text\"}],\"nodeType\":\"paragraph\"},{\"data\":{},\"content\":[{\"data\":{},\"marks\":[],\"value\":\"With Oriola RWE, new information will be available for pharma companies but also for patients, health care professionals, and decision makers.​\",\"nodeType\":\"text\"}],\"nodeType\":\"paragraph\"}],\"nodeType\":\"document\"}","references":[]},"displayName":"Real-World Evidence","referenceLinks":null,"website":"https://www.oriola.com/services/pharmaceutical-companies/real-world-evidence"},{"id":"7f498888-b2f8-5ff2-8f9a-16f5f7322b93","description":{"raw":"{\"data\":{},\"content\":[{\"data\":{},\"content\":[{\"data\":{},\"marks\":[],\"value\":\"Oriola offers a robust suite of market access and tender services designed to help you unlock business opportunities in the Nordic healthcare landscape while overcoming complex access challenges. Our expert team, comprised of experienced pharmaceutical and health economics professionals, provides personalized support that spans from individual price and reimbursement applications to fully outsourced solutions. With Oriola, you gain access to comprehensive market access services, including market analysis, pre-evaluation, and hospital tender management, as well as health technology assessment (HTA) and training led by industry experts.\",\"nodeType\":\"text\"}],\"nodeType\":\"paragraph\"},{\"data\":{},\"content\":[{\"data\":{},\"marks\":[],\"value\":\"Our services streamline pricing and reimbursement processes, offering specialized support in applications, reference price notifications, and budget impact modeling. We tailor health economic models, localized calculators, and advanced analysis to your needs, providing the data and insights required for competitive advantage. Combined with Oriola's Real World Evidence research you will gather local insights, essential for robust, evidence-based health economic reports. With a deep understanding of the Nordic market, we help you navigate regulatory landscapes, refine market strategies, and optimize your market positioning through targeted analyses and strategic consultation.\",\"nodeType\":\"text\"}],\"nodeType\":\"paragraph\"}],\"nodeType\":\"document\"}","references":[]},"displayName":"Market Access","referenceLinks":null,"website":"https://www.oriola.com/services/pharmaceutical-companies/market-access-and-tenders"}],"slug":"oriola","website":"https://www.oriola.com/"}},"pageContext":{"slug":"oriola","language":"en","intl":{"language":"en","languages":["en"],"messages":{"supportedLanguages.en":"EN","supportedLanguages.fi":"FI","authentication.login":"Login","form.areaOfInterest":"Area of interest","form.body":"Your message","form.consent":"I agree to","form.discovery":"How did you find us?","form.email":"Email","form.name":"Your name","form.organization":"Company or organization","form.policy":"privacy policy","form.required":"Required field","form.success.body":"Our team will contact you soon.","form.success.heading":"We have received your message—thank you for reaching out!","form.topic":"Select topic"},"routed":true,"originalPath":"/operators/oriola","redirect":true,"defaultLanguage":"en"},"locale":"en-US"}},
    "staticQueryHashes": ["1648719659","3130670927","3243898050","3265115003","471647045","841752961"]}